Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

883 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ICRF-187 permits longer treatment with doxorubicin in women with breast cancer.
Speyer JL, Green MD, Zeleniuch-Jacquotte A, Wernz JC, Rey M, Sanger J, Kramer E, Ferrans V, Hochster H, Meyers M, et al. Speyer JL, et al. Among authors: meyers m. J Clin Oncol. 1992 Jan;10(1):117-27. doi: 10.1200/JCO.1992.10.1.117. J Clin Oncol. 1992. PMID: 1727913 Clinical Trial.
Medical treatment of metastatic melanoma.
Houghton AN, Meyers ML, Chapman PB. Houghton AN, et al. Among authors: meyers ml. Surg Clin North Am. 1996 Dec;76(6):1343-54. doi: 10.1016/s0039-6109(05)70519-3. Surg Clin North Am. 1996. PMID: 8977555 Review.
Adjuvant therapy of malignant melanoma.
Dickler MN, Coit DG, Meyers ML. Dickler MN, et al. Among authors: meyers ml. Surg Oncol Clin N Am. 1997 Oct;6(4):793-812. Surg Oncol Clin N Am. 1997. PMID: 9309094 Review.
Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer.
Kwa M, Li X, Novik Y, Oratz R, Jhaveri K, Wu J, Gu P, Meyers M, Muggia F, Speyer J, Iwano A, Bonakdar M, Kozhaya L, Tavukcuoglu E, Budan B, Raad R, Goldberg JD, Unutmaz D, Adams S. Kwa M, et al. Among authors: meyers m. Breast Cancer Res Treat. 2018 Feb;168(1):57-67. doi: 10.1007/s10549-017-4570-4. Epub 2017 Nov 9. Breast Cancer Res Treat. 2018. PMID: 29124456 Clinical Trial.
Evaluation of CD8(+) T-cell frequencies by the Elispot assay in healthy individuals and in patients with metastatic melanoma immunized with tyrosinase peptide.
Lewis JJ, Janetzki S, Schaed S, Panageas KS, Wang S, Williams L, Meyers M, Butterworth L, Livingston PO, Chapman PB, Houghton AN. Lewis JJ, et al. Among authors: meyers m. Int J Cancer. 2000 Aug 1;87(3):391-8. doi: 10.1002/1097-0215(20000801)87:3<391::aid-ijc13>3.0.co;2-k. Int J Cancer. 2000. PMID: 10897045 Clinical Trial.
883 results